720-777-0123
-
Conditions & Advice
Parenting Tips and Advice
From bringing home a new baby to building trust with your teen, our pediatric experts share guidance to help you navigate the ups and downs of parenthood.
- Your Visit
-
Research & Innovation
It starts with a Q:
For the latest cutting-edge research, innovative collaborations and remarkable discoveries in child health, read stories from across all our areas of study in Q: Advances and Answers in Pediatric Health.
My care philosophy is to, first and foremost, be honest and forthright with information. I believe that it only in this way that parents and patients can make the best decisions about their care. I also try to engage both the family and the patient in the decision making process when it is possible and appropriate.
Get to know Michael Verneris, MD
My clinical and laboratory interests are in the area of leukemia and in using the immune system to treat cancer, whether that be through bone marrow transplantation or cellular immunotherapy.
Undergraduate 1987
Syracuse University (NY)
Medical Education 1992
Dartmouth Medical School
Internship 1992
Children's National Medical Center/George Washington University Program
Residency 1995
Children's National Medical Center/George Washington University Program
Fellowship 1998
Stanford Hospital and Clinics Program
For Patients:
My laboratory focuses on developing genetically modified T cells, specifically CAR T cells, to effectively target solid tumors. Our research aims to enhance CAR T cell homing, survival, and function within the tumor microenvironment, overcoming key barriers to their efficacy. By optimizing these properties, we seek to improve therapeutic outcomes and advance next-generation immunotherapies for solid tumors.
My laboratory focuses on developing genetically modified T cells, specifically CAR T cells, to effectively target solid tumors. Our research aims to enhance CAR T cell homing, survival, and function within the tumor microenvironment, overcoming key barriers to their efficacy. By optimizing these properties, we seek to improve therapeutic outcomes and advance next-generation immunotherapies for solid tumors.
For Referring Providers:
My laboratory focuses on developing genetically modified T cells, specifically CAR T cells, to effectively target solid tumors. Our research aims to enhance CAR T cell homing, survival, and function within the tumor microenvironment, overcoming key barriers to their efficacy. By optimizing these properties, we seek to improve therapeutic outcomes and advance next-generation immunotherapies for solid tumors.
My laboratory focuses on developing genetically modified T cells, specifically CAR T cells, to effectively target solid tumors. Our research aims to enhance CAR T cell homing, survival, and function within the tumor microenvironment, overcoming key barriers to their efficacy. By optimizing these properties, we seek to improve therapeutic outcomes and advance next-generation immunotherapies for solid tumors.
Anne Stratton, MD
Physical Medicine & Rehabilitation - Pediatric, Pediatrics, Physical Medicine & Rehabilitation
Lisa Hartman, MD
Hematology/Oncology - Pediatric, Pediatrics
Melissa Marvin, CPNP-AC/PC
Certified Pediatric Nurse Practitioner, Certified Pediatric Nurse Practitioner
